ADCT - Adc Therapeutics SA
4.88
0.080 1.639%
Share volume: 1,270,671
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$4.80
0.08
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-06-2024 | 11-07-2024 | 03-27-2025 | 05-14-2025 | 11-10-2025 | |
| Total revenue | 18.053 M | 17.410 M | 18.464 M | 16.910 M | 23.033 M | 16.427 M | |
| Cost of revenue | 2.510 M | 1.217 M | 851.000 K | 1.371 M | 2.061 M | 1.202 M | |
| Gross profit | 15.543 M | 16.193 M | 17.613 M | 15.539 M | 20.972 M | 15.225 M | |
| 4.18% | 8.77% | -11.78% | 34.96% | -27.40% | |||
| Operating expenses | 37.766 M | 34.533 M | 42.504 M | 36.724 M | 38.883 M | 35.129 M | |
| Selling general and admin | 12.031 M | 10.238 M | 10.002 M | 9.623 M | 9.955 M | 8.326 M | |
| Research and development | 25.735 M | 24.295 M | 32.502 M | 27.101 M | 28.928 M | 26.803 M | |
| Total expenses | 49.156 M | 45.234 M | 53.177 M | 47.975 M | 49.436 M | 46.194 M | |
| -7.98% | 17.56% | -9.78% | 3.05% | -6.56% | |||
| Operating income | -33.613 M | -29.041 M | -35.564 M | -32.436 M | -28.464 M | -30.969 M | |
| Ebit | -36.208 M | -26.287 M | -33.940 M | -21.762 M | -28.261 M | -30.044 M | |
| Pretax income | -45.756 M | -35.713 M | -43.619 M | -31.048 M | -38.437 M | -40.966 M | |
| -21.95% | 22.14% | -28.82% | 23.80% | 6.58% | |||
| Income tax | 163.000 K | 234.000 K | 90.000 K | -321.000 K | 165.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -46.606 M | -36.544 M | -43.969 M | -30.727 M | -38.602 M | -40.966 M | |
| 21.59% | -20.32% | 30.12% | -25.63% | -6.12% |